Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphocytic choriomeningitis virus | 2 | 2018 | 176 | 0.670 |
Why?
|
Lymphocytic Choriomeningitis | 2 | 2018 | 140 | 0.600 |
Why?
|
Adenoviruses, Human | 1 | 2018 | 257 | 0.530 |
Why?
|
Cancer Vaccines | 2 | 2021 | 1041 | 0.510 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1061 | 0.460 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1997 | 0.410 |
Why?
|
Viral Vaccines | 1 | 2018 | 596 | 0.410 |
Why?
|
Killer Cells, Natural | 2 | 2018 | 2209 | 0.380 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2018 | 4648 | 0.290 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4405 | 0.250 |
Why?
|
Lymphocyte Depletion | 2 | 2018 | 605 | 0.240 |
Why?
|
Adenoviridae | 2 | 2019 | 1092 | 0.230 |
Why?
|
Melanoma | 1 | 2022 | 5702 | 0.220 |
Why?
|
Tuberculosis Vaccines | 1 | 2020 | 48 | 0.180 |
Why?
|
alpha-Defensins | 1 | 2019 | 30 | 0.170 |
Why?
|
Vaccines, Attenuated | 1 | 2020 | 314 | 0.160 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.150 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2019 | 434 | 0.140 |
Why?
|
Virulence Factors | 1 | 2020 | 498 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1105 | 0.130 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 557 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1574 | 0.120 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4167 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1502 | 0.100 |
Why?
|
Genetic Vectors | 2 | 2019 | 3402 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 22350 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1592 | 0.090 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 545 | 0.090 |
Why?
|
Simian immunodeficiency virus | 1 | 2015 | 814 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8535 | 0.080 |
Why?
|
Macaca mulatta | 3 | 2018 | 2345 | 0.060 |
Why?
|
Vaccination | 1 | 2018 | 3434 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 22361 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4745 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2015 | 2745 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10254 | 0.050 |
Why?
|
Mice | 6 | 2020 | 81912 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 3114 | 0.050 |
Why?
|
Animals | 8 | 2020 | 168965 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6951 | 0.040 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2017 | 13 | 0.040 |
Why?
|
Genes, Bacterial | 1 | 2020 | 1076 | 0.030 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2015 | 30 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2020 | 922 | 0.030 |
Why?
|
Th17 Cells | 1 | 2020 | 790 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 540 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2020 | 836 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 777 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1911 | 0.020 |
Why?
|
Humans | 4 | 2022 | 767040 | 0.020 |
Why?
|
Spleen | 1 | 2015 | 2292 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2815 | 0.020 |
Why?
|
AIDS Vaccines | 1 | 2015 | 900 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2015 | 1377 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3227 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2061 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4401 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3468 | 0.020 |
Why?
|
Female | 2 | 2018 | 396660 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7578 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10455 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9513 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10869 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23621 | 0.010 |
Why?
|
Concepts
(64)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_